Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Salicylic Augmentation in Depression

NCT03152409 is registered in ClinicalTrials.gov with Jessica Harder as lead sponsor.

NCT NCT03152409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03152409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Salicylic Augmentation in Depression
Lead sponsor
Jessica Harder
Phase
Phase 2
Overall status
Terminated
Start date
November 15, 2018
Completion date
February 16, 2021
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, depressive disorder, major depressive disorder, treatment resistant depression